SANTA BARBARA, Calif.--(BUSINESS WIRE)--InTouch Technologies, Inc. (d.b.a InTouch Health), the world leader in Remote Presence health care solutions, announced today that it has entered into a Memorandum of Agreement with Genentech, to facilitate Activase® (Alteplase) education for its growing telestroke customer base. Activase, a recombinant tissue plasminogen activator (t-PA) developed by Genentech, is approved for the management of acute ischemic stroke in adults.
